Ryaltris Interactions
There are 315 drugs known to interact with Ryaltris (mometasone/olopatadine nasal), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 3 are major, and 312 are moderate.
- View all 315 medications that may interact with Ryaltris
- View Ryaltris alcohol/food interactions (1)
- View Ryaltris disease interactions (5)
Most frequently checked interactions
View interaction reports for Ryaltris (mometasone / olopatadine nasal) and the medicines listed below.
- albuterol
- Allegra (fexofenadine)
- aspirin
- atorvastatin
- azelastine nasal
- Benadryl (diphenhydramine)
- CoQ10 (ubiquinone)
- doxycycline
- famotidine
- gabapentin
- ibuprofen
- Lexapro (escitalopram)
- lisinopril
- magnesium glycinate
- magnesium oxide
- montelukast
- Nurtec ODT (rimegepant)
- omeprazole
- pantoprazole
- prednisone
- Singulair (montelukast)
- trazodone
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xyzal (levocetirizine)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Ryaltris alcohol/food interactions
There is 1 alcohol/food interaction with Ryaltris (mometasone / olopatadine nasal).
Ryaltris disease interactions
There are 5 disease interactions with Ryaltris (mometasone / olopatadine nasal) which include:
More about Ryaltris (mometasone / olopatadine nasal)
- Ryaltris consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: nasal antihistamines and decongestants
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.